41.10

1.26% 0.51

Kiniksa Pharmaceuticals International Plc (KNSA)

Overview News Price History Option Chain Financials Discussions Forecast

Kiniksa Pharmaceuticals International Plc stock is traded at $41.10, with a volume of 267.09K. It is up +1.26% in the last 24 hours and up +6.64% over the past month. Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Previous Close:

$40.59

Open:

$40.35

24h Volume:

267.09K

Relative Volume:

0.64

Market Cap:

$3.12B

Revenue:

$384.10M

Net Income/Loss:

$-9.07M

P/E Ratio:

-293.57

EPS:

-0.14

Net Cash Flow:

$11.10M

1W Performance:

-3.39%

1M Performance:

+6.64%

6M Performance:

+42.31%

1Y Performance:

+94.51%

1-Day Range:

$39.79

$41.48

1-Week Range:

$39.61

$42.89

52-Week Range:

$17.82

$42.98

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile

Name

Kiniksa Pharmaceuticals International Plc

Sector

Healthcare (1131)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

(781) 431-9100

Address

23 OLD BOND STREET, FLOOR 3, LONDON

Employee

315

Twitter

@kiniksa

Next Earnings Date

2024-10-29

Latest SEC Filings

KNSA's Discussions on Twitter

Compare KNSA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KNSA Kiniksa Pharmaceuticals International Plc	41.10	3.08B	384.10M	-9.07M	11.10M	-0.14
ZTS Zoetis Inc	120.41	54.02B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	14.28	45.21B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.53	42.35B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	28.41	31.93B	16.70B	-157.13M	1.19B	-0.1446
UTHR United Therapeutics Corp	485.21	20.71B	3.08B	1.24B	1.07B	25.61

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-29-25	Initiated	TD Cowen	Buy
Mar-13-25	Initiated	Citigroup	Buy
Sep-13-24	Initiated	Jefferies	Buy
May-03-24	Initiated	Wells Fargo	Overweight
Jun-29-20	Reiterated	BofA Securities	Buy
Apr-01-20	Initiated	BofA/Merrill	Buy
Mar-11-19	Initiated	Barclays	Overweight
Dec-12-18	Reiterated	Wedbush	Outperform
Jun-19-18	Initiated	JMP Securities	Mkt Outperform

View All

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Latest News

Dec 03, 2025

Wedbush Reiterates Outperform Rating for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) - MarketBeat

Dec 03, 2025

Traders Buy High Volume of Call Options on Kiniksa Pharmaceuticals International (NASDAQ:KNSA) - MarketBeat

Dec 03, 2025

Franklin Resources Inc. Acquires 41,632 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 03, 2025

Kiniksa Pharmaceuticals International’s (KNSA) “Outperform” Rating Reaffirmed at Wedbush - Defense World

Dec 03, 2025

Dec 01, 2025

Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 01, 2025

Nov 29, 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 29, 2025

Nov 28, 2025

Kiniksa (KNSA) Q3 2025 Earnings Call Transcript - The Globe and Mail

Nov 28, 2025

Nov 27, 2025

Wall Street Analysts Think Kiniksa Pharmaceuticals International, plc (KNSA) Could Surge 29.3%: Read This Before Placing a Bet - MSN

Nov 27, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month HighTime to Buy? - MarketBeat

Nov 27, 2025

Nov 25, 2025

AXQ Capital LP Makes New $289,000 Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 25, 2025

Nov 23, 2025

200,574 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Purchased by Hillsdale Investment Management Inc. - MarketBeat

Nov 23, 2025

Nov 21, 2025

Catalyst Funds Management Pty Ltd Takes $493,000 Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 21, 2025

Nov 20, 2025

Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells 12,470 Shares of Stock - MarketBeat

Nov 20, 2025

SG Americas Securities LLC Acquires 127,126 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 20, 2025

Kiniksa Pharma COO Tessari sells shares worth $514,224 By Investing.com - Investing.com India

Nov 20, 2025

Nov 19, 2025

Kiniksa Pharma COO Tessari sells shares worth $514,224 - Investing.com

Nov 19, 2025

[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity - Stock Titan

Nov 19, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 52-Week HighTime to Buy? - MarketBeat

Nov 19, 2025

Los Angeles Capital Management LLC Sells 36,570 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 19, 2025

From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews

Nov 19, 2025

Nov 18, 2025